Skip to main content
Help us understand how you use our websites. Take part in our 30 minute study now.
Download PDF

Genome-wide gene by lead exposure interaction analysis identifies UNC5D as a candidate gene for neurodevelopment

Environmental Health volume 16, Article number: 81 (2017) Cite this article

Abstract

Background

Neurodevelopment is a complex process involving both genetic and environmental factors. Prenatal exposure to lead (Pb) has been associated with lower performance on neurodevelopmental tests. Adverse neurodevelopmental outcomes are more frequent and/or more severe when toxic exposures interact with genetic susceptibility.

Methods

To explore possible loci associated with increased susceptibility to prenatal Pb exposure, we performed a genome-wide gene-environment interaction study (GWIS) in young children from Mexico (n = 390) and Bangladesh (n = 497). Prenatal Pb exposure was estimated by cord blood Pb concentration. Neurodevelopment was assessed using the Bayley Scales of Infant Development.

Results

We identified a locus on chromosome 8, containing UNC5D, and demonstrated evidence of its genome-wide significance with mental composite scores (rs9642758, p meta = 4.35 × 10−6). Within this locus, the joint effects of two independent single nucleotide polymorphisms (SNPs, rs9642758 and rs10503970) had a p-value of 4.38 × 10−9 for mental composite scores. Correlating GWIS results with in vitro transcriptomic profiles identified one common gene, SLC1A5, which is involved in synaptic function, neuronal development, and excitotoxicity. Further analysis revealed interconnected interactions that formed a large network of 52 genes enriched with oxidative stress genes and neurodevelopmental genes.

Conclusions

Our findings suggest that certain genetic polymorphisms within/near genes relevant to neurodevelopment might modify the toxic effects of Pb exposure via oxidative stress.

Peer Review reports

Background

Human development is a trajectory reflecting dynamic processes mediated by constant interplay between genetic background and environmental exposures. Toxic chemicals can alter this trajectory to produce maladaptive cognitive and behavioral phenotypes. Although only a small subset of children exposed to neurotoxicants present a clinically defined developmental disorder, [1], many more exposed individuals probably exhibit subclinical effects, such as reduced IQ. Variability in outcome with the same levels of observed exposures may be explained, in part, by genetic variability that can alter susceptibility to a neurotoxicant. While cognitive development has genetic contributions [2], multiple genome-wide association studies (GWAS) have failed to identify common variants that alone explain the variance in cognition [3,4,5]. Interactions between genetic and environmental factors may account for a large proportion of the variance and may provide useful information on toxicant pathogenesis [6]. In a cohort of Mexican mother-infant pairs, apolipoprotein E genotypes are associated with 24-month Mental Development Index (MDI) of the Bayley Scale, which might modify lead neurotoxicity [7].

The weight of evidence supports an association between early life exposure to lead (Pb) and impaired cognitive function in children [8,9,10]. The central nervous system (CNS) is highly vulnerable to chemical injury during development because critical processes—including neuronal growth, synaptic network formation, neuronal migration, and receptor development—peak during this time [11, 12]. Previous studies have shown that Pb crosses the placenta and accumulates in fetal tissues [13, 14]. While the health effects of early Pb exposure are well described, it remains unclear whether certain individuals are genetically predisposed to adverse outcomes following Pb exposure, as few studies have examined gene–environment (GxE) interactive effects on neurodevelopment. This knowledge is central to understanding the mechanisms of action and to creating effective interventions for prevention and treatment of toxic exposures.

The objective of our study was to examine GxE interactions on neurodevelopmental outcomes in two populations exposed to Pb. We examined prenatal exposure because many genes are expressed only during that specific developmental stage, and also because prenatal exposure has consistently been associated with adverse neurodevelopmental outcomes [15, 16]. Thus, genetic variants that produce GxE interactions may only do so when the exposure timing corresponds to a critical developmental window during which the relevant gene is highly expressed. We conducted a genome-wide GxE interaction study (GWIS) in two birth cohorts of Mexican and Bangladeshi children to identify genetic loci that modify the effect of prenatal Pb exposure on neurodevelopmental scores at approximately 2 years of age. We also performed integrative analyses using in vitro transcriptomic data of Pb-induced changes in human neural stem cells (hNSCs).

Methods

Study populations

Mexico cohort

Between 2007 and 2011, we enrolled participants in the Programming Research in Obesity, Growth, Environment and Social Stressors (PROGRESS) study, a prospective birth cohort to evaluate environmental and social stressors in relation to child growth and development. Recruitment and enrollment have been described previously [17]. Briefly, we recruited healthy pregnant women between 12 and 24 weeks gestation who were living in Mexico City. Women were enrolled from prenatal clinics and maternity hospitals affiliated with the Instituto Mexicano del Seguro Social, the Mexican social security system. The Instituto Mexicano del Seguro Social offers healthcare to private sector, middle-class workers and their families and provides coverage to 34.3% of Mexico City residents (according to 2010 National Census). Eligible participants were at least 18 years of age, had access to a telephone, lived within the Mexico City metropolitan area, and planned to remain there for 3 years. Exclusion criteria included history of heart or kidney disease, daily alcohol consumption, and use of steroids or antiepilepsy drugs. A total of 1054 women were informed about the study and provided written consent to participate. Participating women gave birth to 948 singleton infants, of which 541 were followed until 2 years of age and were available for neurodevelopmental assessment. The human subject committees of the National Institutes of Public Health in Mexico, Harvard T.H. Chan School of Public Health, Icahn School of Medicine at Mt. Sinai, and participating hospitals approved all study materials and procedures.

Bangladesh cohort

Between 2008 and 2011, we recruited pregnant women to participate in a prospective reproductive health cohort to examine the effects of chronic low-level arsenic exposure on reproductive and neurologic health outcomes. As described previously [18], pregnant women were recruited from rural health clinics operated by the Dhaka Community Hospital Trust in the Sirajdikhan and Pabna Sadar Upazilas of Bangladesh. Between 2010 and 2013, health care workers invited families to participate in follow-up studies [19]. All children born during recruitment for the reproductive cohort study were eligible. Informed consent was provided by parents of all participants before enrollment. Reproductive health and follow-up studies were approved by the Human Research Committees at the Harvard T.H. Chan School of Public Health and Dhaka Community Hospital. Boston Children’s Hospital formally ceded review of the follow-up study to the Harvard T.H. Chan School. A total of 1613 women were enrolled in the reproductive health study, of which 1458 had a confirmed singleton pregnancy, were informed about the study, and provided written consent to participate. A total of 964 children participated in follow-up activities.

Lead exposure

Suspected sources of Pb exposure in Mexico include traditional lead glazed pottery, alternative remedies or cosmetics, air pollutants, and nutritional sources [20]; the main source of Pb exposure in Bangladesh is suspected to be food contamination [21]. We collected venous whole blood from pregnant women participating in the Mexico cohort at delivery (± 12 h) using stainless steel phlebotomy needles and a single-stick lead-free vacutainer tube. We collected umbilical cord venous blood in trace element-free tubes at time of delivery from participants in the Bangladesh cohort. Samples were immediately frozen and kept at 4 °C during shipping to the Trace Metals Laboratory at Harvard T.H. Chan School of Public Health (Boston, MA). All samples were processed in a dedicated trace metal cleanroom outfitted with a Class 100 clean hood and using glassware that was cleaned by soaking in 10% HNO3 for 24 h and rinsed several times with 18Ω Milli-Q water. Blood samples were prepared for measurement of lead concentration by first weighing (~1 g) and then digesting samples in 2 mL concentrated HNO3 for 24 h. Samples were treated overnight with 30% hydrogen peroxide (1 mL per 1 g of blood) and then diluted to 10 mL with deionized water. Acid-digested samples were analyzed for total lead with a dynamic reaction cell inductively coupled plasma mass spectrometer (DRC-ICP-MS, Perkin Elmer, Norwalk, CT). The average of five replicate measurements for each individual sample was reported as final value. Recovery rates for lead in quality control and spiked samples were 92%–107%, and precision (percent relative standard deviation) was <10%. All measurements were greater than the average limit of detection, 0.2 μg/dL.

Covariates

Mexico cohort

Study staff interviewed mothers at time of enrollment to obtain demographic data, including age, education (≥high school or <high school), parity, marital status, smoking during pregnancy, and exposure to environmental tobacco smoke. At time of birth, infant sex was recorded and infant birth weight, head circumference, and birth length were abstracted from hospital medical records. Gestational age at birth was estimated based on date of last menstrual period (LMP) and by the Capurro method [22]. LMP was used preferentially; estimates from the Capurro method were used only when the two methods differed by ±3 weeks. Study staff also recorded delivery type (vaginal, forceps, scheduled cesarean section, or emergency cesarean section). Interviewers administered the Home Observation for Measurement of the Environment (HOME) instrument when children were 1–24-months old to characterize the quality and extent of stimulation for children in their home environments [23].

Bangladesh cohort

At enrollment, we interviewed participating women to obtain information on age, education (>primary school or ≤primary school), parity, marital status, smoking history, and socioeconomic status. We assessed socioeconomic status by directly asking husbands their monthly income (<3000 taka, 3000–5000 taka, >5000 taka, or refused to respond). Gestational age at birth was determined by ultrasound measurement taken at time of enrollment, because few women could remember the date of their last menstrual period. Infant sex, birth weight, head circumference, and birth length were recorded at birth. Delivery type (vaginal, forceps, scheduled cesarean section, or emergency cesarean section) was also recorded. For the follow-up study, trained study staff administered questionnaires that collected medical histories and demographic information. Weight, height, and head circumference were measured. Maternal IQ was assessed using Raven’s Indices. Interviewers also administered the HOME instrument that had been previously translated and adapted for use in Bangladesh [23].

Neurodevelopmental outcomes

In Mexico, child neurodevelopment was assessed at approximately 2 years of age using a Spanish version of the Bayley Scales of Infant and Toddler Development, Third Edition (BSID-III). In Bangladesh, we translated the BSID-III into Bengali and adapted it for use in rural Bangladesh (M.M.). Two primary outcomes (mental composite score and motor composite score) were derived by summing across raw scores of cognitive, language, and motor development for each participant: (1) mental development composite score (sum of cognition, expressive language, and receptive language); and (2) motor development composite score (sum of fine motor and gross motor). In both cohorts, trained study personnel who were unaware of participants’ blood Pb levels administered tests using standard protocols. An expert child neurologist (M.M.) and neuropsychologists (D.C.B., L.S.) oversaw administration of BSID-III, and quality control included frequent site visits and review of videotaped administration of neurodevelopmental assessments.

Genotyping

Umbilical cord blood samples were collected at time of delivery from infants in both cohorts using an umbilical cord catheter and Paxgene DNA collection tubes (Qiagen, Venlo, Limberg). DNA was extracted from whole blood samples using Puregene DNA isolation kits (Gentra Systems, Minneapolis, MN) and stored at −20 °C. DNA samples were genotyped using the high density HumanOmni1-Quad BeadChip for the Mexico cohort and Illumina OmniExpressExome-8 BeadChip for the Bangladesh cohort (Illumina, San Diego, CA). Before analysis, a systematic quality evaluation was conducted on raw genotyping data according to the general quality control (QC) procedure described by Anderson [24]. Briefly, unqualified samples were excluded if they fit the following QC criteria: 1) overall genotype completion rates <95%; 2) gender discrepancies; 3) unexpected duplicates or probable relatives (based on pairwise identity by state value, PI_HAT in PLINK >0.185); 4) outlying heterozygosity rates >6 standard deviations from the mean; or 5) subjects identified as outliers using principal components analysis (PCA). Unqualified SNPs were excluded when they fit the following QC criteria: a) SNPs had a call rate < 95% in all samples; b) genotype distributions of SNPs deviated from those expected by Hardy-Weinberg equilibrium (p < 1.0 × 10−6); or c) SNPs were monomorphic in our study samples. After quality evaluation, a genotyping dataset of 552,487 SNPs were available for analysis. We also excluded very low birth weight infants (<1500 g), very premature births (<32 weeks gestation), and participants lacking birth outcomes data. The final sample sizes from the Mexico and Bangladesh cohorts for this analysis were 390 and 497, respectively (Table 1).

Table 1 Demographic characteristics of Bangladesh and Mexico cohorts
Full size table

Mapping SNP to genes

The SNPs were mapped to genes in dbSNP database using GRCh37 build. Initially, for batch operation, we used stricter criteria with a narrow margin of 5 kb up- and down-stream of the RefSeq genes. For top-rank SNPs, we manually searched for all genes within a large 500 kb region flanking each SNP. However, this mapping approach was only used for exploring relevant biological scheme, but lack of the certainty of determining which gene(s) is affected by disease-associated SNPs.

In vitro transcriptomic profiling for Pb toxicity

We previously performed next-generation RNA sequencing on hNSCs to determine the primary transcriptional response to Pb in these cells. hNSCs differentiated from the NIH-approved embryonic stem cell line H9 were grown in cell culture. Cells were exposed to 1 μM Pb and double-distilled water for 24 h before RNA harvesting. cDNA libraries were prepared using an Illumina RNA TruSeq v2 kit and sequenced on an Illumina High Seq 2000 for approximately 50 million reads per sample. Reads were aligned to the genome and gene count tables generated. Sequencing depth was normalized and differential expression called in edgeR implemented in Bioconductor (http://www.bioconductor.org/packages/release/bioc/html/edgeR.html) [25]. For all reported statistically significant results, read alignments were checked manually. Quantitative PCR (qPCR) using SYBR green was used to validate RNA sequencing results. The Pb concentration used in this study, 1 μM, is roughly twice the CDC level of concern for Pb in blood and reasonably estimates blood Pb concentrations observed in study populations [26, 27].

Integrative analysis of GWIS and in vitro transcriptomic data

Incorporating biological functionality can boost the power of genetic mapping. We conducted in silico integrative evaluation of population-based genomic data and complementary in vitro transcriptomic data at gene and network levels to better understand the contribution of GxE interactions, particularly in identifying genes functionally relevant to metal-induced neurodevelopmental outcomes. Our hypothesis was that although candidate gene lists obtained from genomic and transcriptomic studies might or might not overlap at the gene level, there are sets of molecules that directly or indirectly interact with candidate genes at the network level.

We initially mapped a GWIS list of SNPs to a list of genes using SNP Annotation Tool (http://www.snp-nexus.org/). At the gene level, we matched GWIS gene lists and transcriptome gene lists to common identifiers defined by NCBI. From this we identified common gene(s) shared by GWIS and in vitro transcriptomic profiling. At the network level, we uploaded GWIS gene lists together with transcriptome gene lists into MetaCore™ GeneGo database for system biology (Thomson Reuters, New York, NY). Next, we used direct interaction algorithms to build gene network(s) consisting only of uploaded genes and their direct interactions, without adding other genes/objects from the GeneGo database. Finally, we identified and manually removed direct interactions between any pairs of genes either from GWIS or transcriptome lists.

Statistical analysis

All statistical procedures were performed using R version 2.15.2 (https://www.r-project.org/) and PLINK v1.07 (http://zzz.bwh.harvard.edu/plink/). Distributional plots were examined for all variables, and univariate and multivariate regression analyses were conducted to estimate the effect of covariates on neurodevelopment. We log transformed Pb concentrations because the distribution was severely right-skewed with a few outliers.

To adjust for population stratification, we used EigenCorr, a PCA-based method that selects components based on their eigenvalues and their correlation with the phenotype [28]. Based on inspection of PCA plots and a review of literature, it was determined that the first two components would be sufficient to adjust for population stratification in our relatively homogenous samples.

Covariates were selected as potential confounders to include in models when associated with Pb and Bayley scores in bivariate models (p < 0.10) and using LASSO [29]. In both cohorts, the following covariates were included: child’s gender, child’s age at time of neurodevelopmental assessment, gestational age, parity, maternal education (binary), environmental tobacco smoke exposure (binary), and the first two principal components (calculated separately for each cohort). The final model was then: E(Yi) = β0 + β1*Gi + β2*Ei + β3*Gi*Ei + γ*Zi, where Yi is continuous neurodevelopment phenotype (mental or motor composite score), Gi is minor allele count for a given SNP, Ei is log concentration of Pb in maternal or umbilical cord blood, and Zi is vector of additional covariates to adjust for confounding. We did not implement a discovery-replication analytic strategy, because these cohorts had different ethnic backgrounds, different exposure profiles, and the outcomes were assessed independently by teams in countries with different cultures. In addition to cohort-based individual analysis, meta-analyses were conducted by combining results across cohorts for both mental and motor composite scores. We used METAL to combine p-values for each GxE interaction term that was present in both Bangladesh and Mexico cohorts [30].

Results

Demographic characteristics

Demographic characteristics of participating mother–infant pairs from Bangladesh and Mexico cohorts are presented in Table 1. Compared to the Bangladesh cohort, mothers in the Mexico cohort were more likely to be single parents (p < 0.0001), to be older at time of delivery (p < 0.0001), and to deliver infants by Cesarean section (p = 0.0005). Cord blood Pb levels were significantly higher in the Bangladesh cohort (p < 0.0001). Mental composite scores at 2 years were correlated with motor composite scores in both cohorts (Bangladesh: r = 0.666, p < 0.0001; Mexico: r = 0.554, p < 0.0001). Raw mental and motor composite scores were significantly higher in the Bangladesh cohort than Mexico cohort (p < 0.0001), but these raw scores were not yet age-adjusted and differences likely reflect the older age of Bangladeshi children at neurodevelopmental assessment (mean age ± SD = 2.34 ± 0.23 years) compared to Mexican children (mean age ± SD = 2.04 ± 0.05 years). Given the differences in ethnic backgrounds in the two cohorts and that neurodevelopmental outcomes were assessed by different teams, raw scores were used in all analyses. All models were adjusted for age at time of assessment by including age as a covariate.

GWIS of neurodevelopmental outcomes

We performed meta-analyses of genome-wide GxE interactions to identify common genetic variants associated with neurodevelopmental outcomes (mental and motor composite scores, individually) assessed at 2 years of age (Additional file 1: Figure S1). Although none of the 552,487 SNPs reached genome-wide significance in meta-analyses, we identified 20 top-ranked SNPs associated with mental composite score and 21 top-ranked SNPs associated with motor composite score, with p < 0.001 in both cohorts and p meta  < 5 × 10−4 (Table 2). We also identified 18 SNPs associated with mental and motor composite scores with p meta  < 1 × 10−3 in all analyses (Table 3). Many of these SNPs were mapped to genes with biological functions relevant to neurodevelopment (Additional file 2: Table S1). We further explored the functionalities of top-ranked SNPs by investigating Combined Annotation Dependent Deletion (CADD) scaled scores. CADD incorporates a variety of different annotations to predict the genomic substitutions having the most deleterious effects in humans [31]. Out of all GRCh37/hg19 reference SNVs (~8.6 billion), we identified 4 SNPs in the top 10% (CADD score > 10) of most deleterious substitutions in the entire human genome, including rs10015043 (intron variant of gene PALLD, CADD score = 13.68), rs17075573 (intron variant of gene MYRIP, CADD score = 13.66), rs3817591 (3′ UTR variant of gene FMN1, CADD score = 11.19), and rs2276102 (missense variant of gene TMEM135, CADD score = 11.02).

Table 2 Top SNPs demonstrating gene-environment interactions for mental and motor composite scores
Full size table
Table 3 Top SNPs demonstrating gene-environment interactions for both mental and motor composite scores
Full size table

The top locus mapped to chromosome 8 and demonstrated strong association with mental composite score but moderate association with motor composite score (Table 3). For mental composite score, as shown in Fig. 1, the most strongly associated SNP (rs9642758) was located downstream of UNC5D (~87 kb), whereas the second most strongly associated SNP (rs10503970) was located upstream of UNC5D (~220 kb) (Additional file 3: Figure S2 and Additional file 4: Figure S3). UNC5D encodes a receptor for netrin that may be involved in axon guidance by mediating axon repulsion of neuronal growth cones in the developing nervous system [32].

Fig. 1
figure1

Regional association plot showing significant regions around UNC5D on chromosome 8. Results are reported for the most significant SNP, rs9642758, from genome-wide gene–environment effects analysis. Blue circles represent results of mental composite score analysis; red circles represent results of motor composite score. Blue and red diamond symbols represent combined analysis of SNP rs9642758 and rs10503970 for mental composite score and motor composite score, respectively

Full size image

Linkage disequilibrium analysis showed that the two SNPs were in linkage equilibrium (Bangladesh: D’ = 0.228, R2 = 0.001; Mexico: D’ = 0.108, R2 = 0.011) and had comparable main effects and GxE interactive effects on both mental and motor composite scores in each cohort (Table 4 , Additional file 5: Figure S4). We further used IMPUTE2 and the entire 1000 Genomes reference panel to impute the entire region between the two SNPs [33]. None of the imputed SNPs reached the significance level of either of the original SNPs (Additional file 6: Table S4). We next tested the joint effect of these two SNPs by creating a combined SNP, summing the number of minor alleles at rs9642758 and rs10503970. Compared with wild-type genotypes at both sites, the joint effect reached genome-wide significance for GxE interaction in models of mental composite score (p = 4.38 × 10−9), but not motor composite score (p = 1.87 × 10−4) (Table 4). We also conducted the analysis including both SNPs in the same model to evaluate if mild to moderate LD influenced results, but conclusions were unchanged (Additional file 7: Table S5).

Table 4 Joint effect of rs9642758 and rs10503970 locus on Chromosome 8a
Full size table

Gene expression trajectories of top-mapped genes

We examined each top-mapped gene for association with previously defined co-expression networks of a spatiotemporal transcriptome of the human brain and retrieved temporal trajectories of neurodevelopment from the Human Brain Transcriptome public database (http://hbatlas.org/) [34]. Twenty-two of 67 mapped genes were identified in five co-expression networks (Additional file 2: Table S1). The two largest modules, M2 and M20, appeared to be simultaneously co-expressed across all brain regions with opposite developmental trajectories (Additional file 8: Figure S5). The M2 module, containing eight mapped genes, was associated with a progressive increase in gene expression across all brain regions, starting at the embryonic period and remaining at a high level of expression after birth. The M20 module, containing seven mapped genes (including UNC5D), was associated with a progressive decrease in gene expression across all brain regions starting from the embryonic period. A third module, M15, contained three mapped genes and demonstrated a similar neurodevelopmental trajectory as the M2 module, but only in certain regions: the neocortex, hippocampus, amygdala, and striatum.

Integrative analysis of GWIS and in vitro transcriptomic data

To retrieve potential profiles of biological functions associated with genes mapped to top-ranked SNPs, we performed integrative analysis with in vitro transcriptomic data. We previously performed next-generation sequencing of transcripts (RNAseq) in hNSC-derived neurons that were exposed to Pb and identified both known and novel RNA transcripts that are responsive to Pb exposure. This transcriptomic analysis identified that Pb-induced expression was enriched for genes related to oxidative stress and endoplasmic reticulum (ER) stress [35].

Less stringent criteria for GWIS data (p < 0.05 in both cohorts; p meta  < 5 × 10−3) were used to identify 492 SNPs for mental composite score and 578 SNPs for motor composite score, mapped to 210 and 248 genes, respectively. By comparing top lists of genes from our GxE analyses and the list of in vitro transcriptomic analyses, we identified one common gene, SLC1A5, with an intron variant (rs1644343: mental composite score p Mexico  = 0.026; p Bangladesh  = 0.037; and p meta  = 0.0026) that progressively decreased gene expression across all brain regions from embryonic to postnatal periods, with resulting low-level expression after birth (Additional file 8: Figure S5). SLC1A5 encodes an integral membrane transport protein for a neurotransmitter and is potentially involved in synaptic function, neuronal development, and excitotoxicity [36]. In hNSCs, Pb exposure significantly increased expression of SLC1A5 (fold change = 1.3; p = 2.19 × 10−10; FDR = 2.55 × 10−7).

We investigated further the direct gene-gene interactions between top genes from GxE interaction analyses and top genes from in vitro assays. We identified 63 interactions between 44 GxE genes and 28 in vitro genes (Additional file 9: Table S2). Gene Ontology enrichment analysis showed that expression of GxE genes was highly enriched in brain tissue [GO:0043005, neuron projection, p = 2.61 × 10−4; GO:0014069, postsynaptic density, p = 6.11 × 10−3 (with Bonferroni correction)]. Genes’ biological functions were also enriched for nervous system development (GO:0007399, p = 1.30 × 10−9 with Bonferroni correction). The majority of these interactions were interconnected, forming a large network (Fig. 2). Network hub genes (≥5 connections) included two genes (CHUK and TWIST1) from GxE interactions and three genes (PRKCD, HSPA5, and XBP1) from in vitro assays. Interactions included 33 activations (via mechanisms of 13 bindings, 1 cleavage, 1 deubiquitination, 8 phosphorylations, and 10 transcription regulations), 11 inhibitions (via mechanisms of 2 bindings, 2 cleavages, 5 miRNA bindings, and 2 transcription regulations), and 19 unspecified interactions. Thirty-four interactions (54%) were between in vitro genes and GxE genes.

Fig. 2
figure2

Network of directional interactions between GWIS genes and in vitro transcriptomic genes. Round symbols represent genes identified by GWIS. Triangle symbols represent genes selected by in vitro transcriptomic assays, with upward triangles indicating Pb-induced genes and downward triangles indicating Pb-suppressed genes. Biological functions were annotated by NCBI, UCSC Genome Bioinformatics, and literature review

Full size image

Discussion

We present the first multi-ethnic genome-wide study to discover gene–Pb exposure interactions associated with neurodevelopmental outcomes. Although there are distinct ethnic and cultural backgrounds, socioeconomic conditions, and Pb exposure profiles in the two cohorts examined, we identified one locus on chromosome 8 reaching genome-wide significance for joint effects of two independent SNPs (close to linkage equilibrium) on mental composite scores. Within each cohort, the two SNPs had similar main effects and GxE interactive effects, and coefficients for Pb were also similar in magnitude. Results of joint effects of the two SNPs were consistent with effects of individual SNPs and had markedly increased statistical significance. SNPs rs10503970 and rs9642758 are separated by about 855 kb, comprising the entire genomic region of UNC5D, from ~227 kb upstream to ~67 kb downstream, respectively. Moreover, both SNPs were in either strong or moderate linkage disequilibrium (LD) with certain SNPs within UNC5D which might have potential impacts via LD-linked SNPs (Additional file 3: Figure S2). However, there were no known eQTL or functions related to these LD-linked SNPs. Further, this locus contains few genes besides UNC5D, with the closest one (KCNU1) located over 900 kb downstream of SNP rs9642758. Thus, UNC5D appears to be the candidate gene of this locus for GxE interaction on mental development. Similarly, in a study of prostate cancer, despite a weak association between prostate cancer risk and a missense change in HSD3B1 genes, the joint effects of two polymorphisms in the HSD3B gene family demonstrate stronger evidence of association [37].

UNC5D encodes a member of the human dependence receptor UNC5 family for netrin. Netrins control guidance of CNS commissural axons and peripheral motor axons via association with either DCC (DCC netrin 1 receptor) or some UNC5 receptors, leading to axon attraction or repulsion, respectively [38]. UNC5D is specifically expressed in layer 4 of primary sensory areas of the developing neocortex, and thus may be involved in axon guidance by mediating axon repulsion of neuronal growth cones during neurodevelopment [32]. Temporal trajectory profiling from the Human Brain Transcriptome project suggests that expression of UNC5D peaks during mid to late pregnancy, gradually decreases, and is then maintained consistently at a relatively low level after birth (Additional file 8: Figure S5). UNC5D also acts as a dependence receptor required for apoptosis induction when not associated with netrin [39].

A chromosomal breakpoint of apparently balanced chromosome rearrangements was identified in intron 5 of UNC5D in a family with neurodevelopmental disorders [40]. The proband was noted with a developmental delay at 18 months of age affecting walking and speech, as well as with comprehension and behavioral difficulties at 9 years of age. A younger sister with the same translocation had language delay as well as low-to-average fine and gross motor skills at 2 years of age.

In our GxE interaction models, the main effects for Pb levels in prenatal blood were associated with lower mental composite scores in Mexico cohort, but not in the Bangladesh cohort. Pb is a well-known neurotoxicant; nonetheless, some studies have not observed significant adverse associations [41]. A prospective study revealed that fetal lead exposure was associated with the Bayley Mental Developmental Index (MDI) at 3 and 6 months, but no statistically significant relationships were observed with Bayley MDI scores at 3 years of age [42]. There may be several plausible explanations for a lack of a main Pb effect in the 2–4 year old Bangladeshi children, including an exposure range that is too narrow, or co-exposures to other neurotoxicants that may overwhelm a possible lead effect. However, the direction of residual and/or unmeasured confounding by co-exposures could be difficult to predict given the complex correlations between neurotoxicants in different areas of Bangladesh.

We found that minor alleles of SNPs rs10503970 and rs9642758 were significantly associated with lower neurodevelopment scores. However, the coefficient of GxE interaction was positive, which is in the opposite direction of SNPs and Pb exposure (Table 4). We expected to observe a synergy between risk factors resulting in even lower neurodevelopment scores, but our findings contradict this expectation. A direct interpretation of these findings is that, in contrast to the adverse effects of Pb exposure in the presence of wildtype genotypes, Pb exposure counteracts the detrimental effects of minor alleles on mental and motor composite scores at these sites. A possible explanation is that minor alleles may directly or indirectly change the spatial–temporal trajectories of UNC5D expression in the brain, resulting in deleterious effects on neurodevelopment. Pb neurotoxicity can arise by targeting multiple sites at multiple levels—molecular, cellular, inter-cellular, and tissue—which may also perturb spatial–temporal trajectories of UNC5D and offset detrimental effects of minor alleles.

In addition, there was a significant interaction between Pb levels and two SNPs on mental development scores in two genetically different populations and with different distributions of genotypes, strongly suggesting that UNC5D is an important candidate within the biological pathways of Pb neurotoxicity. However, our genome-wide study could not provide further evidence, so future functional research should focus on investigating and comparing the effects of these SNPs on biological functions of UNC5D, especially on spatial–temporal trajectories of brain tissue. Additionally, future research should also examine functional changes of UNC5D induced by Pb exposure.

By cross-evaluation of top gene lists between genome-wide GxE analyses and in vitro global expression profiling induced by Pb treatment, we identified one common gene, SLC1A5, that ranked high (15th) in in vitro transcriptomic assays but ranked relatively low (368th) in GxE analyses for mental composite score (intronic SNP rs1644343). SLC1A5, a member of the solute carrier 1 (SLC1) family, encodes a plasma membrane transporter for the neurotransmitter glutamate [43]. Major functions of glutamate transporters in the brain, expressed in both neurons and astrocytes, are removal of released glutamate from the synaptic cleft and initiation of the recycling cascade for restoring released glutamate in synaptic vesicles. Thus, glutamate transporter malfunction has been implicated in various nervous system diseases [44,45,46].

Pb is a ubiquitous environmental heavy metal pollutant whose toxic effects are principally manifested in the CNS of immature organisms [47]. Even at low doses, Pb is a potent neurodevelopmental toxicant associated with cognitive deficits and related behavioral disturbances [48,49,50,51,52]. The molecular basis of observed changes include selective blockade of glutamatergic synapses with a subsequent decrease in long-term potentiation, which underlies learning and memory processes [53, 54]. A possible mechanism is that all glutamate transporters possess specific cysteine residues with redox-active-SH groups, which regulate glutamate transport via the s-glutathionylation process, and these cysteine residues are vulnerable to biological and chemical oxidants, such as heavy metals. Reduced transporter function leads to neurotoxic levels of extracellular glutamate, resulting in neuronal damage via oxidative and excitotoxic mechanisms, which often operate together [55]. Beyond effects at the protein level, our SLC1A5 results provide evidence that Pb toxicity also has effects at transcriptomic and genomic levels on glutamate transporters.

This study incorporated data from cohorts with different experimental designs and different biomarkers of prenatal Pb exposure. It is therefore not surprising that few common genes (only SLC1A5) could be identified from top-ranked GWAS gene lists and from transcriptomic studies (in vitro RNAseq), because there are subsets of genes from different cohorts that might directly or indirectly interact with each other at the network level under a general biological scheme of Pb neurotoxicity. Using stringent criteria of direct gene–gene interactions between studies with exclusion of interactions within studies, a large 52-gene network of direct gene–gene interactions revealed from integrative analysis supported our hypothesis (Fig. 2). This network had five hub genes (≥5 direct interactions), including two genes from GWIS (CHUK and TWIST1) and three genes from in vitro assays (PRKCD, HSPA5, and XBP1). There were direct interactions among hub genes, further dividing them into two subgroups, XBP1–TWIST1 (21 genes) and PRKCD–CHUK–HSPA5 (31 genes), connected by an interaction between two GWIS-identified genes, PRKCQ and PRKG1.

We found that the network contained three members of the protein kinase C family—PRKCD (PKCδ), PRKCH (PKCη), and PRKCQ (PKCθ)—that are known signal transducers in the CNS, with roles regulating synaptic development and signaling involved in learning and memory [54]. PKC is well established as one of the major molecular targets of Pb toxicity, and the effect of Pb on PKCs depends on Pb concentrations and periods of exposure in different regions of the brain. As a biological and physiological analogue to Ca2+, Pb can directly activate Ca2+-dependent PKCs (α, β1, β2, and γ) at ~1000 times less than the concentration of required calcium [56]. At higher concentrations estimated to exist in the brain tissue of environmentally exposed humans (μM range), Pb inhibits kinase activity of all PKCs in in vitro assays [57, 58]. Interestingly, all three PKCs identified from the network belonged to a PKC subset called novel PKCs (δ, ε, η, and θ), which are Ca2+-independent. Among them, PRKCD was a hub gene with the highest density of connections in the network (15 direct interactions with GWIS-identified genes), and PRKCD expression was significantly increased by Pb treatment (fold change = 1.4; p = 4.0 × 10−4; FDR = 0.055). PKCδ is actively involved in regulation of cell apoptosis, especially through a mitochondrial dysfunction pathway, in response to a large and diverse array of apoptotic stimuli [59]. Oxidative stress, often induced by metal ion exposure, results in overexpression and activation of PKCδ, and activated PKCδ translocates to mitochondria and alters mitochondrial functions, such as decreased membrane potential and release of cytochrome C [60].

Besides PRKCD, the other two hub genes identified from in vitro assays, HSPA5 and XBP1, were key genes in ER stress pathways, a major cellular target of oxidative stress manifested at the maternal–fetal interface from early pregnancy onwards [61]. Growing evidence indicates that some of the toxic effects of Pb are oxidative stress via both ER stress and mitochondrial dysfunction [62]. In vitro studies reveal that Pb exposure upregulates gene and protein expression of HSPA5 (GRP78), a molecular chaperone that binds transiently to proteins traversing through the ER and facilitates their folding, assembly, and transport [63]. Consistently, we observed increased expression of HSPA5 in in vitro assays (fold change = 1.2; p = 1.62 × 10−6; FDR = 7.18 × 10−4). Moreover, Pb directly binds to HSPA5, and Pb-bound HSPA5 stimulates the unfolded protein response of ER stress, which can also be activated by XBP1 [63]. Further, among the remaining 16 network genes identified from in vitro assays, 10 genes were involved in oxidative stress (e.g., CALR, CLU, and HSP90B1, which encode chaperones involved in ER stress) as revealed by literature review and functional annotations at UCSC Genome Bioinformatics (http://genome.ucsc.edu/).

Although evidence suggests that two hub genes identified by GWIS participate in modulation of oxidative stress via the NF-κB pathway [64], both CHUK and TWIST1 play important roles in early neurogenesis by governing cell fate decisions of neural differentiation at the neural crest stage [65, 66]. In contrast to the majority of genes from in vitro assays involved in processes relevant to oxidative stress, many GWIS-identified genes within the network had functions related to neurodevelopment, such as axonogenesis, neurogenesis, and synaptic transmission (Additional file 10: Table S3). Specifically, SLC1A2, also a member of the SLC1 family, encodes another plasma membrane transporter for the neurotransmitter glutamate, and GIRK2 encodes an N-methyl-d-aspartate type of excitatory amino acid receptor. All of these genes are involved in glutamatergic synapses, which are direct targets for Pb’s effects in the brain [54]. Taken together, through a common theme of Pb exposure, enrichment of oxidative stress genes (mainly from in vitro assays) and neurodevelopmental genes (mainly from GWIS) within the large network of integrative analysis suggests that certain genetic polymorphisms within/near genes relevant to neurophysiological functions might modify Pb exposure effects via oxidative stress on neurodevelopmental outcomes.

The major limitation of this study was that Pb exposure was only assessed from blood collected at birth in both cohorts. Several GxE interactions, such as UNC5D and SCL1A5, also play important roles in neurodevelopment during early- or mid-stage pregnancy. On the other hand, neurodevelopment was assessed at 2 years of age, and postnatal Pb exposure, which also is a time critical for neurodevelopment, was not measured [67]. Lack of complete information on timing and duration of Pb exposure might further reduce the power of detecting GxE interactions within two different ethnic groups with relatively small sample sizes. Moreover, study cohorts had significantly different profiles of metal exposure. The Bangladesh population is well known for high-level arsenic exposure in addition to Pb exposure [68]. In a Mexican cohort similar to the present study, we previously found that high manganese co-exposure increased Pb toxicity among young children [49]. Despite the importance of examining joint exposures to toxicants, most previous toxicological studies have focused on a single agent and either do not measure or do not adjust for potential confounders or modifying effects of other chemicals. For the purpose of meta-analysis across cohorts, we also only focused on Pb exposure because it was commonly measured in both cohorts.

Conclusion

In conclusion, GWIS revealed several candidates containing genetic polymorphisms that modified the response to prenatal Pb exposure on neurodevelopmental outcomes. Although their biological functions were generally related to neurodevelopment, these candidates seemed to play different roles at different developmental stages. Follow-up integrative analysis suggested that some of the candidates might have functions via Pb-induced oxidative stress. Our findings highlight the importance of exposure timing that corresponds to a critical developmental window in GxE interaction research. Future research should emphasize comprehensive measurement of exposure at various developmental stages.

Abbreviations

BSID-III:

Bayley Scales of Infant and Toddler Development, Third Edition

CNS:

Central nervous system

ER:

Endoplasmic reticulum

GWAS:

Genome-wide association study

GWIS:

Genome-wide gene-environment interaction study

GxE:

Gene–environment

hNSC:

Human neural stem cell

HOME:

Home Observation for Measurement of the Environment

LD:

Linkage disequilibrium

Pb:

Lead

PCA:

Principal components analysis

QC:

Quality control

qPCR:

Quantitative PCR

RNAseq:

Next-generation sequencing of transcripts

SNP:

Single nucleotide polymorphism

References

  1. 1.

    Grandjean P, Landrigan PJ. Neurobehavioural effects of developmental toxicity. The Lancet Neurol. 2014;13(3):330–8.

    CAS  Article  Google Scholar 

  2. 2.

    Bouchard TJ Jr, McGue M. Familial studies of intelligence: a review. Science. 1981;212(4498):1055–9.

    Article  Google Scholar 

  3. 3.

    Chabris CF, Hebert BM, Benjamin DJ, Beauchamp J, Cesarini D, van der Loos M, Johannesson M, Magnusson PK, Lichtenstein P, Atwood CS, et al. Most reported genetic associations with general intelligence are probably false positives. Psychol Sci. 2012;23(11):1314–23.

    Article  Google Scholar 

  4. 4.

    Davies G, Tenesa A, Payton A, Yang J, Harris SE, Liewald D, Ke X, Le Hellard S, Christoforou A, Luciano M, et al. Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol Psychiatry. 2011;16(10):996–1005.

    CAS  Article  Google Scholar 

  5. 5.

    Davis OS, Butcher LM, Docherty SJ, Meaburn EL, Curtis CJ, Simpson MA, Schalkwyk LC, Plomin R. A three-stage genome-wide association study of general cognitive ability: hunting the small effects. Behav Genet. 2010;40(6):759–67.

    Article  Google Scholar 

  6. 6.

    Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet. 2010;11(6):446–50.

    CAS  Article  Google Scholar 

  7. 7.

    Wright RO, Hu H, Silverman EK, Tsaih SW, Schwartz J, Bellinger D, Palazuelos E, Weiss ST, Hernandez-Avila M. Apolipoprotein E genotype predicts 24-month bayley scales infant development score. Pediatr Res. 2003;54(6):819–25.

    CAS  Article  Google Scholar 

  8. 8.

    Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med. 1987;316(17):1037–43.

    CAS  Article  Google Scholar 

  9. 9.

    Bellinger DC. Lead. Pediatrics. 2004;113(4 Suppl):1016–22.

    Google Scholar 

  10. 10.

    Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, Canfield RL, Dietrich KN, Bornschein R, Greene T, et al. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect. 2005;113(7):894–9.

    CAS  Article  Google Scholar 

  11. 11.

    Rodier PM. Environmental causes of central nervous system maldevelopment. Pediatrics. 2004;113(4 Suppl):1076–83.

    Google Scholar 

  12. 12.

    Faustman EM, Silbernagel SM, Fenske RA, Burbacher TM, Ponce RA. Mechanisms underlying Children's susceptibility to environmental toxicants. Environ Health Perspect. 2000;108(Suppl 1):13–21.

    CAS  Article  Google Scholar 

  13. 13.

    Bressler J, Kim KA, Chakraborti T, Goldstein G. Molecular mechanisms of lead neurotoxicity. Neurochem Res. 1999;24(4):595–600.

    CAS  Article  Google Scholar 

  14. 14.

    Lasley SM, Gilbert ME. Presynaptic glutamatergic function in dentate gyrus in vivo is diminished by chronic exposure to inorganic lead. Brain Res. 1996;736(1–2):125–34.

    CAS  Article  Google Scholar 

  15. 15.

    Bellinger D, Sloman J, Leviton A, Rabinowitz M, Needleman HL, Waternaux C. Low-level lead exposure and children's cognitive function in the preschool years. Pediatrics. 1991;87(2):219–27.

    CAS  Google Scholar 

  16. 16.

    Bellinger DC, Stiles KM, Needleman HL. Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study. Pediatrics. 1992;90(6):855–61.

    CAS  Google Scholar 

  17. 17.

    Burris HH, Braun JM, Byun HM, Tarantini L, Mercado A, Wright RJ, Schnaas L, Baccarelli AA, Wright RO, Tellez-Rojo MM. Association between birth weight and DNA methylation of IGF2, glucocorticoid receptor and repetitive elements LINE-1 and Alu. Epigenomics. 2013;5(3):271–81.

    CAS  Article  Google Scholar 

  18. 18.

    Kile ML, Rodrigues EG, Mazumdar M, Dobson CB, Diao N, Golam M, Quamruzzaman Q, Rahman M, Christiani DC. A prospective cohort study of the association between drinking water arsenic exposure and self-reported maternal health symptoms during pregnancy in Bangladesh. Environ Health. 2014;13(1):29.

    Article  Google Scholar 

  19. 19.

    Gleason K, Shine JP, Shobnam N, Rokoff LB, Suchanda HS, Ibne Hasan MO, Mostofa G, Amarasiriwardena C, Quamruzzaman Q, Rahman M, et al. Contaminated turmeric is a potential source of lead exposure for children in rural Bangladesh. J Environ Public Health. 2014;2014:730636.

    Article  Google Scholar 

  20. 20.

    Renzetti S, Just AC, Burris HH, Oken E, Amarasiriwardena C, Svensson K, Mercado-Garcia A, Cantoral A, Schnaas L, Baccarelli AA, et al. The association of lead exposure during pregnancy and childhood anthropometry in the Mexican PROGRESS cohort. Environ Res. 2017;152:226–32.

    CAS  Article  Google Scholar 

  21. 21.

    Hossain S, Bhowmick S, Jahan S, Rozario L, Sarkar M, Islam S, Basunia MA, Rahman A, Choudhury BK, Shahjalal H. Maternal lead exposure decreases the levels of brain development and cognition-related proteins with concomitant upsurges of oxidative stress, inflammatory response and apoptosis in the offspring rats. Neurotoxicology. 2016;56:150–8.

    CAS  Article  Google Scholar 

  22. 22.

    Capurro H, Konichezky S, Fonseca D, Caldeyro-Barcia R. A simplified method for diagnosis of gestational age in the newborn infant. J Pediatr. 1978;93(1):120–2.

    CAS  Article  Google Scholar 

  23. 23.

    Caldwell BM, Bradley RH. Home observation for measurement of the environment: administration manual. Tempe: Family & Human Dynamics Research Institute, Arizona State University; 2003.

    Google Scholar 

  24. 24.

    Anderson CA, Pettersson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT. Data quality control in genetic case-control association studies. Nat Protoc. 2010;5(9):1564–73.

    CAS  Article  Google Scholar 

  25. 25.

    Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–40.

    CAS  Article  Google Scholar 

  26. 26.

    Pirkle JL, Brody DJ, Gunter EW, Kramer RA, Paschal DC, Flegal KM, Matte TD. The decline in blood lead levels in the United States. The National Health and nutrition examination surveys (NHANES). JAMA. 1994;272(4):284–91.

    CAS  Article  Google Scholar 

  27. 27.

    Zheng L, Wu K, Li Y, Qi Z, Han D, Zhang B, Gu C, Chen G, Liu J, Chen S, et al. Blood lead and cadmium levels and relevant factors among children from an e-waste recycling town in China. Environ Res. 2008;108(1):15–20.

    CAS  Article  Google Scholar 

  28. 28.

    Lee S, Wright FA, Zou F. Control of population stratification by correlation-selected principal components. Biometrics. 2011;67(3):967–74.

    Article  Google Scholar 

  29. 29.

    Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Ser B Methodol. 1996;58(1):267–88.

    Google Scholar 

  30. 30.

    Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26(17):2190–1.

    CAS  Article  Google Scholar 

  31. 31.

    Kircher M, Witten D, Jain P, O'Roak B, Cooper G, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310–5.

    CAS  Article  Google Scholar 

  32. 32.

    Takemoto M, Hattori Y, Zhao H, Sato H, Tamada A, Sasaki S, Nakajima K, Yamamoto N. Laminar and areal expression of unc5d and its role in cortical cell survival. Cereb Cortex. 2011;21(8):1925–34.

    Article  Google Scholar 

  33. 33.

    Howie B, Marchini J, Stephens M. Genotype imputation with thousands of genomes. G3 (Bethesda). 2011;1(6):457–70.

    Article  Google Scholar 

  34. 34.

    Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, Sousa AM, Pletikos M, Meyer KA, Sedmak G, et al. Spatio-temporal transcriptome of the human brain. Nature. 2011;478(7370):483–9.

    CAS  Article  Google Scholar 

  35. 35.

    Wagner PJ, Park HR, Wang Z, Kirchner R, Wei Y, Su L, Stanfield K, Guilarte TR, Wright RO, Christiani DC, Lu Q. In Vitro Effects of Lead on Gene Expression in Neural Stem Cells and Associations between Upregulated Genes and Cognitive Scores in Children. Environ Health Perspect. 2017;125(4):721–29.

  36. 36.

    Shao Z, Kamboj A, Anderson CM. Functional and immunocytochemical characterization of D-serine transporters in cortical neuron and astrocyte cultures. J Neurosci Res. 2009;87(11):2520–30.

    CAS  Article  Google Scholar 

  37. 37.

    Chang BL, Zheng SL, Hawkins GA, Isaacs SD, Wiley KE, Turner A, Carpten JD, Bleecker ER, Walsh PC, Trent JM, et al. Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility. Cancer Res. 2002;62(6):1784–9.

    CAS  Google Scholar 

  38. 38.

    Keleman K, Dickson BJ. Short- and long-range repulsion by the drosophila Unc5 netrin receptor. Neuron. 2001;32(4):605–17.

    CAS  Article  Google Scholar 

  39. 39.

    Wang H, Ozaki T, Shamim Hossain M, Nakamura Y, Kamijo T, Xue X, Nakagawara A. A newly identified dependence receptor UNC5H4 is induced during DNA damage-mediated apoptosis and transcriptional target of tumor suppressor p53. Biochem Biophys Res Commun. 2008;370(4):594–8.

    CAS  Article  Google Scholar 

  40. 40.

    Utami KH, Hillmer AM, Aksoy I, Chew EG, Teo AS, Zhang Z, Lee CW, Chen PJ, Seng CC, Ariyaratne PN, et al. Detection of chromosomal breakpoints in patients with developmental delay and speech disorders. PLoS One. 2014;9(6):e90852.

    Article  Google Scholar 

  41. 41.

    Gardella C. Lead exposure in pregnancy: a review of the literature and argument for routine prenatal screening. Obstet Gynecol Surv. 2001;56(4):231–8.

    CAS  Article  Google Scholar 

  42. 42.

    Dietrich KN, Succop PA, Bornschein RL, Krafft KM, Berger O, Hammond PB, Buncher CR. Lead exposure and neurobehavioral development in later infancy. Environ Health Perspect. 1990;89:13–9.

    CAS  Article  Google Scholar 

  43. 43.

    Grewer C, Gameiro A, Rauen T. SLC1 glutamate transporters. Pflugers Arch. 2014;466(1):3–24.

    CAS  Article  Google Scholar 

  44. 44.

    Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol. 1996;40(5):759–66.

    CAS  Article  Google Scholar 

  45. 45.

    Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 1992;326(22):1464–8.

    CAS  Article  Google Scholar 

  46. 46.

    Seki Y, Feustel PJ, Keller RW Jr, Tranmer BI, Kimelberg HK. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke. 1999;30(2):433–40.

    CAS  Article  Google Scholar 

  47. 47.

    Needleman HL. Childhood lead poisoning. Curr Opin Neurol. 1994;7(2):187–90.

    CAS  Article  Google Scholar 

  48. 48.

    Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med. 2003;348(16):1517–26.

    CAS  Article  Google Scholar 

  49. 49.

    Claus Henn B, Schnaas L, Ettinger AS, Schwartz J, Lamadrid-Figueroa H, Hernandez-Avila M, Amarasiriwardena C, Hu H, Bellinger DC, Wright RO, et al. Associations of early childhood manganese and lead coexposure with neurodevelopment. Environ Health Perspect. 2012;120(1):126–31.

    Article  Google Scholar 

  50. 50.

    Bellinger DC. Very low lead exposures and children's neurodevelopment. Curr Opin Pediatr. 2008;20(2):172–7.

    Article  Google Scholar 

  51. 51.

    Roy A, Bellinger D, Hu H, Schwartz J, Ettinger AS, Wright RO, Bouchard M, Palaniappan K, Balakrishnan K. Lead exposure and behavior among young children in Chennai, India. Environ Health Perspect. 2009;117(10):1607–11.

    CAS  Article  Google Scholar 

  52. 52.

    Bellinger DC. Neurological and behavioral consequences of childhood lead exposure. PLoS Med. 2008;5(5):e115.

    Article  Google Scholar 

  53. 53.

    Struzynska L. A glutamatergic component of lead toxicity in adult brain: the role of astrocytic glutamate transporters. Neurochem Int. 2009;55(1–3):151–6.

    CAS  Article  Google Scholar 

  54. 54.

    Toscano CD, Guilarte TR. Lead neurotoxicity: from exposure to molecular effects. Brain Res Brain Res Rev. 2005;49(3):529–54.

    CAS  Article  Google Scholar 

  55. 55.

    Trotti D, Danbolt NC, Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci. 1998;19(8):328–34.

    CAS  Article  Google Scholar 

  56. 56.

    Coppi AA, Lesniak J, Zieba D, Schanne FA. The effects of lead on PKC isoforms. Ann N Y Acad Sci. 2000;919:304–6.

    CAS  Article  Google Scholar 

  57. 57.

    Sun X, Tian X, Tomsig JL, Suszkiw JB. Analysis of differential effects of Pb2+ on protein kinase C isozymes. Toxicol Appl Pharmacol. 1999;156(1):40–5.

    CAS  Article  Google Scholar 

  58. 58.

    Rajan MT, Jagannatha Rao KS, Mamatha BM, Rao RV, Shanmugavelu P, Menon RB, Pavithran MV. Quantification of trace elements in normal human brain by inductively coupled plasma atomic emission spectrometry. J Neurol Sci. 1997;146(2):153–66.

    CAS  Article  Google Scholar 

  59. 59.

    Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase c delta. Apoptosis. 2003;8(1):19–27.

    CAS  Article  Google Scholar 

  60. 60.

    Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V. Role of proteolytic activation of protein kinase Cdelta in oxidative stress-induced apoptosis. Antioxid Redox Signal. 2003;5(5):609–20.

    CAS  Article  Google Scholar 

  61. 61.

    Burton GJ, Jauniaux E. Oxidative stress. Best Pract Res Clin Obstet Gynaecol. 2011;25(3):287–99.

    Article  Google Scholar 

  62. 62.

    Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update. 2006;12(6):747–55.

    CAS  Article  Google Scholar 

  63. 63.

    Qian Y, Tiffany-Castiglioni E. Lead-induced endoplasmic reticulum (ER) stress responses in the nervous system. Neurochem Res. 2003;28(1):153–62.

    CAS  Article  Google Scholar 

  64. 64.

    Floc'h N, Kolodziejski J, Akkari L, Simonin Y, Ansieau S, Puisieux A, Hibner U, Lassus P. Modulation of oxidative stress by twist oncoproteins. PLoS One. 2013;8(8):e72490.

    Article  Google Scholar 

  65. 65.

    Luningschror P, Kaltschmidt B, Kaltschmidt C. Knockdown of IKK1/2 promotes differentiation of mouse embryonic stem cells into neuroectoderm at the expense of mesoderm. Stem Cell Rev. 2012;8(4):1098–108.

    Article  Google Scholar 

  66. 66.

    Vincentz JW, Firulli BA, Lin A, Spicer DB, Howard MJ, Firulli AB. Twist1 controls a cell-specification switch governing cell fate decisions within the cardiac neural crest. PLoS Genet. 2013;9(3):e1003405.

    CAS  Article  Google Scholar 

  67. 67.

    Braun JM, Hoffman E, Schwartz J, Sanchez B, Schnaas L, Mercado-Garcia A, Solano-Gonzalez M, Bellinger DC, Lanphear BP, Hu H, et al. Assessing windows of susceptibility to lead-induced cognitive deficits in Mexican children. Neurotoxicology. 2012;33(5):1040–7.

    CAS  Article  Google Scholar 

  68. 68.

    McCarty KM, Senn DB, Kile ML, Quamruzzaman Q, Rahman M, Mahiuddin G, Christiani DC. Antimony: an unlikely confounder in the relationship between well water arsenic and health outcomes in Bangladesh. Environ Health Perspect. 2004;112(8):809–11.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The authors thank Dr. Hakon Hakonarson of U Pennsylvania and Dr. Maegan Harden of the Broad Institute.

Funding

This work was supported in part by National Institute of Environmental Health Sciences grants: R01-ES007821, R01-ES014930, R01-ES013744, R00-ES022986, and P30-ES00002, and by Science to Achieve Results Research Assistance Agreement No. FP-91690001, awarded by the U.S. Environmental Protection Agency (EPA). EPA has not officially endorsed this publication and the views expressed herein may not reflect the views of the EPA.

Availability of data and materials

The genotyping and phenotyping dataset is submitting to the dbGaP depository with the title “Genetic Epidemiology of Neurodevelopment Toxicity” (Accession number: phs000996.v1.p1).

Author information

Author notes

    Affiliations

    1. Harvard TH Chan School of Public Health, Boston, MA, USA

      Zhaoxi Wang, Li Su, Ryan Sun, Han Chen, Peter J. Wagner, Quan Lu, Xihong Lin, David Bellinger, Maitreyi Mazumdar & David C. Christiani

    2. Department of Environmental Health, Boston University, School of Public Health, Boston, USA

      Birgit Claus Henn

    3. Genome Institute of Singapore, Singapore, Singapore

      Chaolong Wang

    4. Department of Epidemiology, Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China

      Yongyue Wei

    5. Mt. Sinai School of Medicine, New york, USA

      Robert Wright

    6. Children’s Hospital Boston, Boston, USA

      David Bellinger & Maitreyi Mazumdar

    7. Oregon State University, Corvallis, USA

      Molly Kile

    8. Instituto Nacional de Salud Publica, Cuernavaca, Mexico

      Martha Maria Tellez-Rojo

    9. Instituto Nacional de Perinatologia, Mexico City, Mexico

      Lourdes Schnaas

    Authors
    1. Zhaoxi Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Birgit Claus Henn
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Chaolong Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Yongyue Wei
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Li Su
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Ryan Sun
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Han Chen
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Peter J. Wagner
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Quan Lu
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Xihong Lin
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. Robert Wright
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. David Bellinger
      View author publications

      You can also search for this author in PubMed Google Scholar

    13. Molly Kile
      View author publications

      You can also search for this author in PubMed Google Scholar

    14. Maitreyi Mazumdar
      View author publications

      You can also search for this author in PubMed Google Scholar

    15. Martha Maria Tellez-Rojo
      View author publications

      You can also search for this author in PubMed Google Scholar

    16. Lourdes Schnaas
      View author publications

      You can also search for this author in PubMed Google Scholar

    17. David C. Christiani
      View author publications

      You can also search for this author in PubMed Google Scholar

    Contributions

    Project leader: DCC. Project design: XL, ROW, DB, MK, MM, MTR, LS, and DCC. Sample collection and phenotyping: LS, MK, MTR, and DCC. Genotyping: LS, and YW. In vitro transcriptomic profiling: PJW and QL. Statistical analysis: ZW, BCH, CW, YW, RS, HC, PJW, XL, and DCC. Writing: ZW, BCH, and MM. All authors read and approved the final manuscript.

    Corresponding author

    Correspondence to David C. Christiani.

    Ethics declarations

    Ethics approval and consent to participate

    All participants provided written, informed consent upon enrollment. The human subject committees of the National Institutes of Public Health in Mexico, Harvard T.H. Chan School of Public Health, Icahn School of Medicine at Mt. Sinai, and participating hospitals approved all study materials and procedures.

    Consent for publication

    Not applicable.

    Competing interests

    The authors have no conflicts of interest to disclose.

    Publisher’s Note

    Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    Additional files

    Additional file 1: Figure S1.

    Q-Q plots of GWIS. (DOCX 9 mb)

    Additional file 2: Table S1.

    Functional annotation of GWIS genes. (XLSX 19 kb)

    Additional file 3: Figure S2.

    LD structures of chromosome 8 locus containing gene UNC5D. (DOCX 3 mb)

    Additional file 4: Figure S3.

    The stratified scatterplots show how the effect of Pb on Mental and Motor Composite Score is modified by the number of minor alleles at the two top SNPs. In particular, we can see how both scores appear to fall as Pb increases for subjects with no minor alleles (black symbols), but scores appear to rise as Pb increases for subjects with one minor alleles (blue symbols). This trend occurs for both SNPs and both outcomes, showing the significant interaction effect between the two SNPs and Pb concentration. (DOCX 169 kb)

    Additional file 5: Figure S4.

    Manhattan plots displaying genetic effects from genome-wide association of meta-analysis on mental or motor composite scores. (DOCX 5 mb)

    Additional file 6: Table S4.

    Result of Imputed SNPs between rs9642758 and rs10503970. (XLSX 170 kb)

    Additional file 7: Table S5.

    Analysis Gene-environment Interactions with Two SNPs. (XLSX 9 kb)

    Additional file 8: Figure S5.

    Spatial and temporal expression trajectories of top genes associated with neurodevelopmental outcomes. (DOCX 1 mb)

    Additional file 9: Table S2.

    Integrative analysis of direct gene-gene interactions between GWIS genes and in vitro transcriptomic assay genes. (XLSX 18 kb)

    Additional file 10: Table S3.

    Functional annotation of genes from integrative analysis. (XLSX 49 kb)

    Rights and permissions

    Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Wang, Z., Claus Henn, B., Wang, C. et al. Genome-wide gene by lead exposure interaction analysis identifies UNC5D as a candidate gene for neurodevelopment. Environ Health 16, 81 (2017). https://doi.org/10.1186/s12940-017-0288-3

    Download citation

    Keywords

    • Genome-wide association study
    • Gene-environment interactions
    • Child development
    • Lead poisoning
    • Single nucleotide polymorphism
    • UNC5D
    • SLC1A5
    • Environmental health

    Environmental Health

    ISSN: 1476-069X